44 Moreover, anergic cells normally keep a greater susceptibility to apoptosis Until anti-apoptotic proteins including BCL2 are overexpressed, as is the case for CLL cells.45 Without a doubt, most key therapeutic improvements happening in the last 10 years are related to the inhibition of BCR and BCL2-mediated signaling.Even with all latest therape